Managing and Analysing Adverse Drug Event Reports

Build a working method for adverse drug event analysis that stands up to scrutiny and survives daily pressure.

📍 Cairo🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points

Course Overview

Cost pressure and quality expectations on adverse drug event analysis are rising at the same time. Accreditation bodies assess event analysis on documented evidence of consistent practice. Participants finish able to explain this area of health and pharmaceutical services to a non-specialist audience without losing precision. What blocks progress on adverse drug event analysis is usually unclear ownership rather than unclear intent. Mature organisations treat this strand of health and pharmaceutical services as a standing capability rather than a project that finishes. It suits anyone whose decisions touch event analysis, in large organisations and small ones alike. The programme is built to be used, and every section of adverse drug event analysis it covers ends in something applicable. Each session closes with a decision the participant must justify about event analysis in their own setting. The closing exercise tests whether the participant's plan for the wider health and pharmaceutical services agenda survives a hostile question.

Expected Learning Outcomes

01

Plan staffing and rota cover appropriate to demand in adverse drug event analysis.

02

Establish incident and near-miss reporting on event analysis that staff trust.

03

Set the minimum documentation for adverse drug event analysis that is genuinely necessary, and stop there.

04

Audit event analysis in practice, not only in policy.

05

Integrate adverse drug event analysis into existing management routines rather than running it separately.

06

Document decisions about event analysis in a form that remains useful after the people change.

07

Design a process for adverse drug event analysis that clinical staff can follow without obstructing care.

Who Should Attend

01

Team leaders and supervisors who put adverse drug event analysis into practice day to day.

02

Business partners who must understand event analysis well enough to challenge it.

03

Accreditation and compliance officers preparing evidence on adverse drug event analysis.

04

Quality and patient safety officers monitoring event analysis.

05

Nursing managers and clinical supervisors delivering adverse drug event analysis.

06

Supply chain and biomedical staff supporting event analysis.

Course Modules

01

Adverse drug event analysis: staffing, capacity and demand

2 sessions · 8 points

Session 1Making incident reporting on adverse drug event analysis safe for staff

  • Agree the indicators that will show whether adverse drug event analysis is improving.
  • Identify where judgement in event analysis is legitimate and where it is not.
  • Define the trigger that would require adverse drug event analysis to be redesigned.
  • Identify single points of dependency in event analysis and reduce them.

Session 2Auditing event analysis at the bedside, not in the binder

  • Record the rationale for each significant choice made about adverse drug event analysis.
  • Assemble the accreditation evidence pack for event analysis.
  • Match staffing levels on adverse drug event analysis to measured demand across the week.
  • Select quality indicators for event analysis that measure outcome rather than activity.
02

Event analysis: infection prevention and patient safety

2 sessions · 8 points

Session 1Comparing event analysis with recognised practice

  • Map the clinical workflow for adverse drug event analysis as it is actually performed.
  • Write down the assumptions underpinning the approach to event analysis.
  • Collect evidence on the present handling of adverse drug event analysis before proposing changes.
  • Assign responsibility for keeping documentation of event analysis current.

Session 2Designing event analysis so it helps rather than obstructs care

  • Cost adverse drug event analysis per episode and identify avoidable waste.
  • Estimate the resource event analysis requires to run as designed.
  • Arrange the handover of adverse drug event analysis so capability survives staff changes.
  • Draft the minimum viable clinical protocol for event analysis.
03

Event analysis: clinical process design and workflow

2 sessions · 8 points

Session 1Building lasting competence in event analysis

  • Agree the smallest change to adverse drug event analysis that would be visibly useful.
  • Confirm the incident reporting route for event analysis is quick and non-punitive.
  • Measure patient experience of adverse drug event analysis and feed it back to the team.
  • Set out how exceptions to event analysis are requested and approved.

Session 2Investigating an adverse event involving adverse drug event analysis

  • Record what was learned when adverse drug event analysis did not go as planned.
  • Apply structured root cause analysis to the last adverse event involving event analysis.
  • Verify cold chain and storage conditions for materials used in adverse drug event analysis.
  • Confirm licensing and regulatory requirements applying to event analysis are met.
04

Event analysis: cost, efficiency and sustainability of the service

2 sessions · 8 points

Session 1Medication safety checkpoints inside event analysis

  • Confirm patient data handled within adverse drug event analysis meets confidentiality obligations.
  • Plan continuity of event analysis during surge and outbreak conditions.
  • Reduce unwarranted variation in adverse drug event analysis between shifts and sites.
  • Confirm that those complying with event analysis understand why it exists.

Session 2Keeping event analysis alive after the initial push

  • Check that consent processes within adverse drug event analysis are genuinely informed.
  • Prepare the response for the most likely failure in event analysis.
  • Build medication safety checks into adverse drug event analysis at the point of highest risk.
  • Define escalation criteria for deterioration detected through event analysis.

Choose the package that suits you

Silver Package

At least 3 people

USD1,250
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Gold Package

At least 3 people

USD1,850
  • 5-night stay in a 5-star hotel
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Complete your registration

We will contact you within one business day to confirm.